AMRINONE LACTATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amrinone Lactate, and when can generic versions of Amrinone Lactate launch?
Amrinone Lactate is a drug marketed by Baxter Hlthcare Corp, Hikma, and Hospira. and is included in three NDAs.
The generic ingredient in AMRINONE LACTATE is inamrinone lactate. There is one drug master file entry for this compound. Additional details are available on the inamrinone lactate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMRINONE LACTATE?
- What are the global sales for AMRINONE LACTATE?
- What is Average Wholesale Price for AMRINONE LACTATE?
Summary for AMRINONE LACTATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Patent Applications: | 3,032 |
| DailyMed Link: | AMRINONE LACTATE at DailyMed |
US Patents and Regulatory Information for AMRINONE LACTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | AMRINONE LACTATE | inamrinone lactate | INJECTABLE;INJECTION | 075542-001 | May 10, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | AMRINONE LACTATE | inamrinone lactate | INJECTABLE;INJECTION | 075513-001 | May 9, 2000 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | AMRINONE LACTATE | inamrinone lactate | INJECTABLE;INJECTION | 074616-001 | Aug 3, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
